Pilulka Lekarny AS (XPRA:PINK) ROC (Joel Greenblatt) %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
47 GF Score
Price Kč124.00
GF Value Kč111.21
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS ROC (Joel Greenblatt) %?

Pilulka Lekarny AS XPRA:PINK +6.90% 47 ROC (Joel Greenblatt) % is 0.00% as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 47/100 and a GF Value™ of Kč111.21 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Pilulka Lekarny AS ranks worse than 83.98% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Pilulka Lekarny AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Pilulka Lekarny AS's ROC (Joel Greenblatt) % or its related term are showing as below:

XPRA:PINK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -289.58   Med: -114.76   Max: -48.96
Current: -142.88

During the past 6 years, Pilulka Lekarny AS's highest ROC (Joel Greenblatt) % was -48.96%. The lowest was -289.58%. And the median was -114.76%.

XPRA:PINK's ROC (Joel Greenblatt) % is ranked worse than
83.98% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 12.625 vs XPRA:PINK: -142.88

Pilulka Lekarny AS's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -34.60% per year.


Pilulka Lekarny AS  (XPRA:PINK) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Pilulka Lekarny AS ROC (Joel Greenblatt) % Related Terms


Pilulka Lekarny AS ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS ROC (Joel Greenblatt) % Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial -48.96 -86.63 -250.63 -289.58 -142.88

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Pilulka Lekarny AS ROC (Joel Greenblatt) % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's ROC (Joel Greenblatt) % falls into.


XPRA:PINK
47GF Score
Pilulka Lekarny AS XPRA:PINK
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(67.449 + 54.739 + 4.071) - (181.718 + 0 + 99.187)
=-154.646

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.332 + 63.375 + 10.312) - (156.638 + 0 + 16.498)
=-60.117

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Pilulka Lekarny AS for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (21.137 + max(-154.646, 0)) + (9.005 + max(-60.117, 0)) )/ 2 )
=0/( ( 21.137 + 9.005 )/ 2 )
=0/15.071
=0.00 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 0.00% mean?
Pilulka Lekarny AS (XPRA:PINK) has a ROC (Joel Greenblatt) % of 0.00% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pilulka Lekarny AS and its competitors. According to the industry distribution chart, Pilulka Lekarny AS ranks #561 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 84%.
Is Pilulka Lekarny AS's ROC (Joel Greenblatt) % too high?
Pilulka Lekarny AS's current ROC (Joel Greenblatt) % is 0.00%. Based on the distribution chart, Pilulka Lekarny AS ranks #561 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pilulka Lekarny AS has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pilulka Lekarny AS ranks #561 out of 668 companies for ROC (Joel Greenblatt) %. This places Pilulka Lekarny AS in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.63, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pilulka Lekarny AS and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pilulka Lekarny AS's current ROC (Joel Greenblatt) % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Modestly Overvalued. The stock's GF Value™ is Kč111.21, compared to a current price of Kč124.00 — trading 11.5% above its estimated fair value. The current ROC (Joel Greenblatt) % is 0.00%. Pilulka Lekarny AS's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current ROC (Joel Greenblatt) % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued. The current stock price of Kč124.00 is trading 11.5% above its estimated GF Value™ of Kč111.21. GuruFocus considers Pilulka Lekarny AS to be Modestly Overvalued.

Key valuation signals for XPRA:PINK:

  • ROC (Joel Greenblatt) %: 0.00%
  • GF Value™: Kč111.21 vs. price of Kč124.00 (11.5% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
47GF Score

Get the complete analysis for XPRA:PINK

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč124.00
Price
Kč111.21
GF Value